Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation

Joseph A. Sparano, Scott Wadler, Robert B. Diasio, Ruiwen Zhang, Zhihang Lu, Edward L. Schwartz, Avi Einzig, Peter H. Wiernik

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation'. Together they form a unique fingerprint.

Medicine & Life Sciences